Mitochondrial Liaisons of p53
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Mitochondria play a central role in cell survival and cell death. While producing the bulk of intracellular ATP, mitochondrial respiration represents the most prominent source of harmful reactive oxygen species. Mitochondria participate in many anabolic pathways, including cholesterol and nucleotide biosynthesis, yet also control multiple biochemical cascades that contribute to the programmed demise of cells. The tumor suppressor protein p53 is best known for its ability to orchestrate a transcriptional response to stress that can have multiple outcomes, including cell cycle arrest and cell death. p53-mediated tumor suppression, however, also involves transcription-independent mechanisms. Cytoplasmic p53 can physically interact with members of the BCL-2 protein family, thereby promoting mitochondrial membrane permeabilization. Moreover, extranuclear p53 can suppress autophagy, a major prosurvival mechanism that is activated in response to multiple stress conditions. Thirty years have passed since its discovery, and p53 has been ascribed with an ever-increasing number of functions. For instance, p53 has turned out to influence the cell's redox status, by transactivating either anti- or pro-oxidant factors, and to regulate the metabolic switch between glycolysis and aerobic respiration. In this review, we will analyze the mechanisms by which p53 affects the balance between the vital and lethal functions of mitochondria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism
MITCHELL, P. (1961) · Nature · doi:10.1038/191144a0 · Cited by 4,704
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 9×
“BAK p53 target gene (activator RE) p53-interacting protein Proapoptotic member of the BCL-2 protein family (105, 120, 184, 188, 190) BAX p53 target gene (activator RE) p53-interacting protein Proapoptotic member of the BCL-2 protein family (37, 105, 158, 184)”
InfluentialSelf-citationClassification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399 · cited 3×
“…nuclear fragmentation (karyorrhexis), usually no (or very slight) modifications of cytoplasmic organelles, plasma membrane blebbing (but persistence of its integrity until the final stages of the process), and engulfment of apoptotic bodies by local phagocytes ( in vivo ) (69, 104, 106).”
InfluentialSelf-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 4×
“These apparently counterintuitive prosurvival activities of the p53 system presumably reflect a high degree of complexity that has not yet been entirely disentangled (244).”
InfluentialA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337 · cited 3×
“The Warburg effect provides cancer cells with consistent advantages during oncogenesis, including the possibility to mobilize energy stores in a rather rapid fashion (which is required to sustain the massive biosynthesis of intracellular structures in highly proliferating cells) and a limited sensitivity to varying ox…”
Self-citationPUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315 · cited 10×
“Lethal proteins whose promoter contains a functional p53 RE of the activator type include proapoptotic members of the BCL-2 protein family such as BAD (96), BAK (184, 190), BAX (158, 184), BID (211), BOK (256), NOXA (also known as phorbol-12-myristate-13-acetate-induced protein 1) (174, 256), and PUMA (168), as well a…”
InfluentialShimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178 · cited 1×
“Importantly, PTPC interactors include both anti- and proapoptotic BCL-2-like proteins, such as BAX (10, 20, 145, 214, 215, 235), BAK (214, 235), BID (266), BCL-2 (10, 20, 146, 214, 235), and BCL-XL (215, 235), suggesting some degree of crosstalk between MOMP and MPT.”
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112 · cited 2×
“NOXA (PMAIP1) p53 target gene (activator RE) BH3-only protein of the derepressor type (35, 174, 251, 256) NRF2 p53 target gene (inhibitor RE) Antioxidant transcriptional factor (56) OSGIN1 (OKL38, BDGI) p53 target gene (activator RE) Localizes at mitochondria and stimulates CYTC release (246, 257)”
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 5×
“BAK p53 target gene (activator RE) p53-interacting protein Proapoptotic member of the BCL-2 protein family (105, 120, 184, 188, 190) BAX p53 target gene (activator RE) p53-interacting protein Proapoptotic member of the BCL-2 protein family (37, 105, 158, 184)”
InfluentialTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 13×
“As in most instances TIGAR lowers F2,6BP levels, p53mediated overexpression of TIGAR results in the block of glycolysis at the fructose-6-phosphate stage and in the redirection of glucose catabolism toward the oxidative branch of the pentose phosphate pathway (PPP) (12).”
InfluentialThe p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967 · cited 2×
“, p53 transactivates MDM2, thereby selfrestraining its own activity (81)], as well as by another oncosuppressor protein, ARF, which acts by sequestering MDM2 in the nucleolus (therefore preventing the MDM2=p53 interaction) (91).”
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 6×
“, DNA damage, oncogene activation, nutrient deprivation, hypoxia, and many others), the p53 protein can undergo multiple kinds of reversible post-translational modification, which are mediated by distinct upstream signal transduction mechanisms, yet all reduce the affinity of p53 for MDM2 and hence favor its stabiliza…”
InfluentialRheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911 · cited 2×
“SCO2 p53 target genes (activator RE) Key regulator of mitochondrial respiration (150) TFAM p53-interacting protein Cooperates with p53 for mtDNA maintenance (253, 261) TIGAR p53 target gene (activator RE) Inhibitor of glycolysis with antioxidant properties (12) TP53INP1 p53 target gene (activator RE) Antioxidant prote…”
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
The p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 15×
“PUMA p53 target gene (activator RE) BH3-only protein of the activator type (35, 168, 251) SCO2 p53 target gene (activator RE) Indirectly favors ROS overgeneration (26, 150, 245) TP53I3 (PIG3) p53 target gene (activator RE) Quinone oxidoreductase involved in the early cellular response to DNA damage (61, 119, 191, 193)”
InfluentialKruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 4×
“…deprivation, hypoxia, and many others), the p53 protein can undergo multiple kinds of reversible post-translational modification, which are mediated by distinct upstream signal transduction mechanisms, yet all reduce the affinity of p53 for MDM2 and hence favor its stabilization (109, 200) (Fig.”
InfluentialZamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.367 · Cited by 1,567
Self-citationAutophagic cell death: the story of a misnomer
Kroemer, G., & Levine, B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2529 · Cited by 1,453 · cited 1×
“Thus, autophagy constitutes a critical cytoprotective mechanism, as demonstrated by the fact that its pharmacological or genetic inhibition most often accelerates cell death (rather than preventing it) (17, 107), and may indeed facilitate the survival of cancer cells that experience metabolic and=or chemotherapeutic s…”
Self-citationDRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., Gasco, M., Garrone, O., Crook, T., & Ryan, K. M. (2006) · Cell · doi:10.1016/j.cell.2006.05.034 · Cited by 1,380 · cited 2×
“These genes code for the b1 and b2 subunits of AMPactivated protein kinase (AMPK) (58), an evolutionary conserved protein that responds to decreased ATP:AMP ratios, thereby acting a sensor of intracellular energy levels (59); tuberous sclerosis complex (TSC) protein 2 (TSC2) (58), which—in complex with TSC1—can transd…”
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326 · cited 6×
“MnSOD p53 target gene (activator RE) Antioxidant enzyme (86) PGM p53 target gene (inhibitor RE) Glycolytic enzyme, converts 3PG into 2PG (100, 208) p53R2 p53 target gene (activator RE) Contributes to maintenance=biogenesis of mitochondria (15) PTGES (PIG12) p53 target gene (activator RE) Prostaglandin-isomerizing and…”
InfluentialAMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168 · cited 11×
“Importantly, PTPC interactors include both anti-and proapoptotic BCL-2-like proteins, such as BAX (10, 20, 145, 214, 215, 235), BAK (214, 235), BID (266), BCL-2 (10, 20, 146, 214, 235), and BCL-X L (215, 235), suggesting some degree of crosstalk between MOMP and MPT.”
InfluentialSelf-citationZamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1661 · Cited by 1,166
Self-citationRegulation of autophagy by cytoplasmic p53
Tasdemir, E., Maiuri, M. C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1730 · Cited by 1,132
Self-citationRole of BNIP3 and NIX in cell death, autophagy, and mitophagy
Zhang, J., & Ney, P. A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.16 · Cited by 1,021 · cited 4×
“These genes code for the b 1 and b 2 subunits of AMP-activated protein kinase (AMPK) (58), an evolutionary conserved protein that responds to decreased ATP:AMP ratios, thereby acting a sensor of intracellular energy levels (59); tuberous sclerosis complex (TSC) protein 2 (TSC2) (58), which—in complex with TSC1—can tra…”
InfluentialVousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959 · cited 6×
“PUMA p53 target gene (activator RE) BH3-only protein of the activator type (35, 168, 251) SCO2 p53 target gene (activator RE) Indirectly favors ROS overgeneration (26, 150, 245) TP53I3 (PIG3) p53 target gene (activator RE) Quinone oxidoreductase involved in the early cellular response to DNA damage (61, 119, 191, 193)”
InfluentialA ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death
Kroemer, G., El-Deiry, W. S., Golstein, P., Peter, M. E., Vaux, D., Vandenabeele, P., Zhivotovsky, B., Blagosklonny, M. V., Malorni, W., Knight, R. A., et al. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401724 · Cited by 843 · cited 3×
“Biochemical features that have been used to define apoptosis include the exposure of the phospholipid phosphatidylserine on the outer leaflet of the plasma membrane and the massive activation of caspases (69, 104, 106), evolutionarily conserved serine proteases cleaving after an Asp residue (39) that also participate…”
Self-citationCell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832 · cited 4×
“Biochemical features that have been used to define apoptosis include the exposure of the phospholipid phosphatidylserine on the outer leaflet of the plasma membrane and the massive activation of caspases (69, 104, 106), evolutionarily conserved serine proteases cleaving after an Asp residue (39) that also participate…”
InfluentialSelf-citationp53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810 · cited 1×
“Alternative splicing of the human TP53 gene leads to the synthesis of at least eight distinct p53 isoforms, whose tissue specificity, functions, and mutual interactions remain largely unknown (16, 40, 197, 203).”
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804 · cited 2×
“Indeed, whereas low amounts of MDM2 stimulate (poly)-monoubiquitination and nuclear export of p53, high levels promote its polyubiquitination and degradation (123).”
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Williams, A., Sarkar, S., Cuddon, P., Ttofi, E. K., Saiki, S., Siddiqi, F. H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.79 · Cited by 800 · cited 1×
“Nevertheless, multiple intracellular structures can also be specifically tagged for autophagic degradation (262), including proteotoxins (196, 207, 250), peroxisomes (57), damaged endoplasmic reticulum (230), invading pathogens (121), and uncoupled mitochondria (a process that has been baptized ‘‘mitophagy’’) (169, 23…”
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738 · cited 1×
“Two nuclear export signals are located at aa 11–27 (transactivation domain) and at aa 340–351 (oligomerization domain), whereas three nuclear localization signals have been identified at aa 316–324 (oligomerization domain), aa 370–376, and aa 380–386 (both in the C-terminal domain) (125, 223).”
Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD
Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V., & Chumakov, P. M. (2004) · Science · doi:10.1126/science.1095569 · Cited by 731
The complexity of p53 stabilization and activation
Lavin, M. F., & Gueven, N. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401925 · Cited by 701 · cited 1×
“These posttranslational modifications include phosphorylation (which is highly prevalent for the N-terminal transactivation domain, containing the most famous Ser15 and Ser46 activation residues), methylation (which specifically targets the oligomerization domain of p53), acetylation, neddylation, and sumoylation (all…”
MDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · cited 1×
“Additional MDM2-like proteins have been described that regulate p53 functions, in particular MDMX (also known as MDM4) (216).”
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · cited 9×
“Thus, although PGM is negatively regulated by p53 in fibroblasts (100), its p53-dependent transactivation has been shown to contribute to myoblastic differentiation (208).”
InfluentialFeng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633
Apaf-1 is a transcriptional target for E2F and p53
Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K. (2001) · Nature Cell Biology · doi:10.1038/35078527 · Cited by 593 · cited 2×
“APAF1 p53 target gene (activator RE) Postmitochondrial mediator of intrinsic apoptosis (105, 162, 202)”
Zalckvar, E., Berissi, H., Mizrachy, L., Idelchuk, Y., Koren, I., Eisenstein, M., Sabanay, H., Pinkas‐Kramarski, R., & Kimchi, A. (2009) · The EMBO Reports · doi:10.1038/embor.2008.246 · Cited by 592 · cited 2×
“These genes code for the b1 and b2 subunits of AMPactivated protein kinase (AMPK) (58), an evolutionary conserved protein that responds to decreased ATP:AMP ratios, thereby acting a sensor of intracellular energy levels (59); tuberous sclerosis complex (TSC) protein 2 (TSC2) (58), which—in complex with TSC1—can transd…”
Transcription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
Trinei, M., Giorgio, M., Cicalese, A., Barozzi, S., Ventura, A., Migliaccio, E., Milia, E., Padura, I. M., Raker, V. A., Maccarana, M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205513 · Cited by 436 · cited 2×
“p66 p53 target gene (activator RE) Adaptor protein involved in the regulation of mitochondrial ROS production and lifespan (155, 181, 234)”
BID regulation by p53 contributes to chemosensitivity
Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., & El-Deiry, W. S. (2002) · Nature Cell Biology · doi:10.1038/ncb866 · Cited by 420 · cited 7×
“Lethal proteins whose promoter contains a functional p53 RE of the activator type include proapoptotic members of the BCL-2 protein family such as BAD (96), BAK (184, 190), BAX (158, 184), BID (211), BOK (256), NOXA (also known as phorbol-12-myristate-13-acetate-induced protein 1) (174, 256), and PUMA (168), as well a…”
InfluentialPospisilik, J. A., Knauf, C., Joza, N., Benit, P., Orthofer, M., Cani, P. D., Ebersberger, I., Nakashima, T., Sarao, R., Neely, G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.047 · Cited by 404 · cited 2×
“AIF p53 target gene (activator RE) IMS protein required for complex I assembly=stability (66, 194, 222, 236) ALDH4 p53 target gene (activator RE) Antioxidant enzyme involved in proline degradation (260) AMID p53 target gene (activator RE) Redox-active mitochondrial flavoprotein (143, 255) AMPK b1 AMPK b2 p53 target ge…”
Self-citationKeeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
Marine, J.-C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., & Lozano, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401912 · Cited by 352 · cited 1×
“Negative regulation of p53 is crucial for organismal survival, as illustrated by the fact that mdm2 = mice die early during embryonic development as a direct consequence of the failure to restrain p53-mediated apoptosis (142).”
PpAtg30 Tags Peroxisomes for Turnover by Selective Autophagy
Farré, J.-C., Manjithaya, R., Mathewson, R. D., & Subramani, S. (2008) · Developmental Cell · doi:10.1016/j.devcel.2007.12.011 · Cited by 331 · cited 1×
“Nevertheless, multiple intracellular structures can also be specifically tagged for autophagic degradation (262), including proteotoxins (196, 207, 250), peroxisomes (57), damaged endoplasmic reticulum (230), invading pathogens (121), and uncoupled mitochondria (a process that has been baptized ‘‘mitophagy’’) (169, 23…”
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
Regulation of the Human hsp70 Promoter by p53
Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292 · cited 1×
“Further, p53-mediated transactivation of specific target genes has been associated with the regulation of DNA repair (163, 217, 226, 227); positive and negative feedback loops in the p53 pathway (81); autophagy and autophagy-related signal transduction cascades (58, 59, 135); bioenergetic metabolism (12, 150); the cyt…”
Monoubiquitylation promotes mitochondrial p53 translocation
Marchenko, N. D., Wolff, S., Erster, S., Becker, K., & Moll, U. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601560 · Cited by 286
Effects of genetic background on tumorigenesis in p53‐deficient mice
Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A., Park, S. H., Thompson, T., Ford, R. J., & Bradley, A. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140105 · Cited by 252
Zhao, Y., Chaiswing, L., Velez, J. M., Batinic-Haberle, I., Colburn, N. H., Oberley, T. D., & St. Clair, D. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3835 · Cited by 245 · cited 3×
“Fourth, p53 has been shown to physically interact with manganese SOD at mitochondria (see above), eventually resulting in Dcm dissipation (273).”
Autophagy mediates pharmacological lifespan extension by spermidineand resveratrol
Morselli, E., Galluzzi, L., Kepp, O., Criollo, A., Maiuri, M. C., Tavernarakis, N., Madeo, F., & Kroemer, G. (2009) · Aging · doi:10.18632/aging.100110 · Cited by 213
Self-citationMdmX Protects p53 from Mdm2-Mediated Degradation
Jackson, M. W., & Berberich, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1001-1007.2000 · Cited by 211 · cited 1×
“Intriguingly, although MDMX shares with MDM2 the ability to bind p53 and also proficiently represses p53 transactivation, MDMX can stimulate neither the nuclear export of p53 nor its degradation, and actually appears to protect p53 from MDM2-mediated suppression (93).”
Liu, G., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205862 · Cited by 207
Regulation of AIF expression by p53
Stambolsky, P., Weisz, L., Shats, I., Klein, Y., Goldfinger, N., Oren, M., & Rotter, V (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401965 · Cited by 194
Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis
Drane, P., Bravard, A., Bouvard, V., & May, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204101 · Cited by 180 · cited 2×
“MnSOD p53 target gene (inhibitor RE) p53-interacting protein Antioxidant enzyme (51, 273)”
Bid acts on the permeability transition pore complex to induce apoptosis
Zamzami, N., Hamel, C. E., Maisse, C., Brenner, C., Muñoz-Pinedo, C., Belzacq, A.-S., Costantini, P., Vieira, H., Loeffler, M., Molle, G., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1204030 · Cited by 178 · cited 6×
“Importantly, PTPC interactors include both anti-and proapoptotic BCL-2-like proteins, such as BAX (10, 20, 145, 214, 215, 235), BAK (214, 235), BID (266), BCL-2 (10, 20, 146, 214, 235), and BCL-X L (215, 235), suggesting some degree of crosstalk between MOMP and MPT.”
InfluentialSelf-citationp53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice
Tan, T., & Chu, G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3247-3254.2002 · Cited by 167
CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation
Burns, D. M., & Richter, J. D. (2008) · Genes & Development · doi:10.1101/gad.1697808 · Cited by 134
Cited by
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Self-citationInhibiting eukaryotic transcription: which compound to choose? How to evaluate its activity
Bensaude, O. (2011) · Transcription · doi:10.4161/trns.2.3.16172 · Cited by 574
Guo, X., Disatnik, M.-H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., & Qi, X. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70911 · Cited by 370
Eischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161
De, S., Kumari, J., Mudgal, R., Modi, P., Gupta, S., Futami, K., Goto, H., Lindor, N. M., Furuichi, Y., Mohanty, D., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101501 · Cited by 107
Metadata
- Authors
- Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-09-15
- Volume
- 15
- Issue
- 6
- Pages
- 1691-1714
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2000501612
- Cited by
- 74
- References
- 61
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.